header image

Corporate News

Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A

22.01.2018

Lachen, Switzerland, January 22nd, 2018: Octapharma is delighted to announce the publication of final data from a Good Clinical Practice (GCP) trial in PUPs in the internationally renowned medical journal Haemophilia. The study...

Schweiz News

Leider gibts es für diesen Archivzeitraum keine übersetzten Artikel.